Cite
Martínez-López I, Maurino J, Sanmartín-Fenollera P, et al. Assessing Pharmacists' Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis. Pharmacy (Basel). 2020;8(2)doi: 10.3390/pharmacy8020061.
Martínez-López, I., Maurino, J., Sanmartín-Fenollera, P., Ontañon-Nasarre, A., Santiago-Pérez, A., Moya-Carmona, I., García-Collado, C. G., Fernández-Del Olmo, R., García-Arcelay, E., Sarmiento, M., Carreño, �. �., & Pérez-Encinas, M. (2020). Assessing Pharmacists' Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis. Pharmacy (Basel, Switzerland), 8(2), . https://doi.org/10.3390/pharmacy8020061
Martínez-López, Iciar, et al. "Assessing Pharmacists' Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis." Pharmacy (Basel, Switzerland) vol. 8,2 (2020). doi: https://doi.org/10.3390/pharmacy8020061
Martínez-López I, Maurino J, Sanmartín-Fenollera P, Ontañon-Nasarre A, Santiago-Pérez A, Moya-Carmona I, García-Collado CG, Fernández-Del Olmo R, García-Arcelay E, Sarmiento M, Carreño Á, Pérez-Encinas M. Assessing Pharmacists' Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis. Pharmacy (Basel). 2020 Apr 07;8(2). doi: 10.3390/pharmacy8020061. PMID: 32272683; PMCID: PMC7356901.
Copy
Download .nbib